Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #501 to #550.
- ASZ1 (1 revision)
- ASTL (1 revision)
- 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
- ATC code A (1 revision)
- ASCC3 (1 revision)
- ACY1 (1 revision)
- ATC code H01 (1 revision)
- AD-36 (1 revision)
- ALDH1L1 (1 revision)
- ADAM11 (1 revision)
- AGPAT9 (1 revision)
- ADAM17 (1 revision)
- ADAM8 (1 revision)
- ADAMTS4 (1 revision)
- AFF3 (1 revision)
- ADAMTS9 (1 revision)
- ABT-239 (1 revision)
- 5-HT receptor (1 revision)
- 5-Hydroxyindoleacetic acid (1 revision)
- 5-Hydroxytryptophan (1 revision)
- 5-Lipoxygenase activating protein (1 revision)
- ADCC (1 revision)
- 5-MeO-AET (1 revision)
- ADCY10 (1 revision)
- 5-MeO-DALT (1 revision)
- 5-MeO-DET (1 revision)
- 5-MeO-DMT (1 revision)
- 5-MeO-DPT (1 revision)
- 5-MeO-MiPT (1 revision)
- 5-MeO-NMT (1 revision)
- 5-MeO-pyr-T (1 revision)
- 5-MeS-DMT (1 revision)
- 5-Methoxy-diisopropyltryptamine (1 revision)
- 5-Methylcytosine (1 revision)
- 5-Methylindole (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 5-Methyltetrahydrofolate-homocysteine methyltransferase (1 revision)
- AIP (gene) (1 revision)
- ACCN1 (1 revision)
- AGPAT5 (1 revision)
- 5-alpha-reductase deficiency case study one (1 revision)
- AFTPH (1 revision)
- 60S ribosomal protein L37 (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- ACAT2 (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- ALDH1B1 (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- ACBD3 (1 revision)
- AGXT2 (1 revision)